Huntington National Bank’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1 | Hold |
1
| – | – | ﹤0.01% | 4136 |
|
|
2025
Q4 | $1 | Hold |
1
| – | – | ﹤0.01% | 4039 |
|
|
2025
Q3 | $1 | Hold |
1
| – | – | ﹤0.01% | 4069 |
|
|
2025
Q2 | $1 | Hold |
1
| – | – | ﹤0.01% | 4079 |
|
|
2025
Q1 | $1 | Hold |
1
| – | – | ﹤0.01% | 4090 |
|
|
2024
Q4 | $1 | Hold |
1
| – | – | ﹤0.01% | 4085 |
|
|
2024
Q3 | $1 | Hold |
1
| – | – | ﹤0.01% | 4077 |
|
|
2024
Q2 | $1 | Hold |
1
| – | – | ﹤0.01% | 4026 |
|
|
2024
Q1 | $1 | Hold |
1
| – | – | ﹤0.01% | 3893 |
|
|
2023
Q4 | $1 | Hold |
1
| – | – | ﹤0.01% | 3790 |
|
|
2023
Q3 | $1 | Hold |
1
| – | – | ﹤0.01% | 3761 |
|
|
2023
Q2 | $1 | Hold |
1
| – | – | ﹤0.01% | 3707 |
|
|
2023
Q1 | $1 | Hold |
1
| – | – | ﹤0.01% | 3578 |
|
|
2022
Q4 | $1 | Hold |
1
| – | – | ﹤0.01% | 3441 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3141 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 3144 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 3069 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2994 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2715 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2605 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2496 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2472 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2416 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2432 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2525 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2532 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2441 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2475 |
|
|
2018
Q1 | – | Sell |
-50
| Closed | – | – | 1780 |
|
|
2017
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 1760 |
|
|
2017
Q3 | $0 | Buy |
+50
| New | +$19 | ﹤0.01% | 1730 |
|
Huntington National Bank's GCVRZ Position: Q1 2026 in Review
Huntington National Bank held its Sanofi Contingent Value Rights (GCVRZ) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4136.
Huntington National Bank first reported a position in GCVRZ in Q3 2017 and has held it in 30 quarters since. 1 fund tracked by Wall St. Rank holds GCVRZ as of Q1 2026.
- Huntington National Bank held 1 share of Sanofi Contingent Value Rights worth $1 as of Q1 2026.
- Huntington National Bank left its Sanofi Contingent Value Rights share count unchanged in Q1 2026.
- Sanofi Contingent Value Rights made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4136 holding.
- Huntington National Bank first reported a position in Sanofi Contingent Value Rights in Q3 2017 and has held it in 30 quarters since.
- 1 fund tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.